IL6 and myeloid sarcoma: At week 16, this study showed a significant increase in tumor necrosis factor-alpha (TNF-α) (*, p < 0.05), while no significant changes were observed in interleukin-6 (IL-6) and interleukin-1 beta (IL-1β) (p > 0.05) in the adipose tissue of the MS group compared to the C group (Figure 7a–c).